Sunday 11 October 2026 Export all CE data to Excel Powerpack

Celanese Corporation

CE Basic Materials Chemicals

Celanese Corporation’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, down 7.05% from fiscal 2024. In the quarter to June 2026, revenue grew 8.69%, EPS fell 37.4%, free cash flow fell 53.6% and total debt fell 7.22%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

45.02 0.21 +0.47%
Market cap
$4.9B
P/E
0.0×
Fwd P/E
9.6×
Dividend yield
0.27%
F-score
5/9
Altman Z
1.23
Beneish M
−3.03
Dividend safety
29/100

Insider Decisions trades per month

Total buys 0.59
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — 2 — — — — — — — 3 — —
Sell — — — — — — — — — — — —
Insider Ownership 0.42%

Capital & Financial Ratios $m

Market Cap 4,920.00
Revenue 9,712.00
Net Income (1,154.00)
Free Cash Flow 708.00
Net Debt 10,643.00
Current Ratio 1.45
Debt/Equity 2.62 (above 2: weak)
P/E ratio 0.00
Fwd P/E 9.56
P/S ratio 0.51
P/B ratio 1.08
Past 5Y EPS Growth —
This Y EPS Growth 50.68% (at or above 15%: strong)
Next Y EPS Growth 4.96%
Next Y revenue growth 4.94%
Next 5Y EPS Growth 22.84% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/S against its own 10 years 5.47%
10-year low 10-year high
P/B against its own 10 years 8.71%
10-year low 10-year high
EV/Sales against its own 10 years 5.50%
10-year low 10-year high
EV/FCF against its own 10 years 54.47%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate 0.12
Annual Dividend Yield 0.27%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 0.12
0.03
0.03
0.03
2025 0.12
0.03
0.03
0.03
0.03
2024 2.80
0.70
0.70
0.70
0.70
2023 2.80
0.70
0.70
0.70
0.70
2022 2.74
0.68
0.68
0.68
0.70
2021 2.72
0.68
0.68
0.68
0.68
2020 2.48
0.62
0.62
0.62
0.62
2019 2.40
0.54
0.62
0.62
0.62
2018 2.08
0.46
0.54
0.54
0.54
2017 1.74
0.36
0.46
0.46
0.46
2016 1.38
0.30
0.36
0.36
0.36
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 1,805 962 1,263 1,364
Receivables 1,784 1,614 1,467 1,869
Inventory 2,357 2,284 2,220 2,305
Other 272 266 743 257
6,218 5,126 5,693 5,795
2023 2024 2025 Q'26
Payables 1,510 1,228 1,279 1,485
ST’ Debt 1,383 1,501 1,204 1,311
Other 1,154 1,157 1,124 1,106
4,072 3,890 3,683 4,006

Compound Annual Growth %

10y 5y 3y
Sales 5.34% 11.03% (0.45%)
Cash Flow 2.89% (3.12%) (14.27%)
Earnings 0.00% 0.00% 0.00%
Book Value 4.69% 2.80% (9.86%)

Revenue $m

Mar Jun Sep Dec Year
’26 2,337 2,752 — — —
’25 2,389 2,532 2,419 2,204 9,544
’24 2,611 2,651 2,648 2,358 10,268
’23 2,853 2,795 2,723 2,555 10,926
’22 2,538 2,486 2,301 2,348 9,673
’21 1,798 2,198 2,266 2,275 8,537
’20 1,460 1,193 1,411 1,591 5,655
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 76 209 — — —
’25 37 410 447 252 1,146
’24 101 292 79 494 966
’23 (96) 762 403 830 1,899
’22 316 495 467 541 1,819
’21 116 427 630 584 1,757
’20 259 379 431 274 1,343
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 10 147 — — —
’25 (65) 317 383 168 803
’24 (36) 187 (9) 389 531
’23 (260) 617 272 702 1,331
’22 179 371 328 398 1,276
’21 24 317 528 421 1,290
’20 140 291 359 189 979
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.40 1.13 — — —
’25 (0.19) 1.81 (12.39) 0.17 (10.64)
’24 1.10 1.41 1.06 (17.50) (13.93)
’23 0.83 2.01 8.69 6.37 17.92
’22 4.61 3.98 1.75 7.03 17.34
’21 2.82 4.77 4.56 4.79 16.86
’20 1.82 0.90 1.75 12.50 16.75
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.9
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 55.07 78.38 82.91 87.23 52.70 115.42 86.71 97.12 66.73 35.13

Analyst estimates 2026–2028

Powerpack
High 84.97 109.70 119.29 128.88 138.31 174.05 176.50 159.06 172.16 75.84
People
People Employees 7,293 7,592 7,684 7,714 7,658 8,529 13,263 12,410 12,163 11,434
Revenue/emp, $m 0.74 0.81 0.93 0.82 0.74 1.00 0.73 0.88 0.84 0.83
Income, $m
Income, $m Revenue 5,389 6,140 7,155 6,297 5,655 8,537 9,673 10,926 10,268 9,544
Gross margin, % 26.07 24.61 27.56 25.50 22.86 31.42 24.60 23.64 22.75 20.45
EBT 1,030 1,075 1,510 988 2,251 2,248 1,421 1,161 (1,019) (1,220)
EBT margin, % 19.11 17.51 21.10 15.69 39.81 26.33 14.69 10.63 (9.92) (12.78)
Net income 906 849 1,213 858 1,992 1,896 1,902 1,947 (1,534) (1,151)
Depreciation 295 310 349 356 356 378 478 739 823 786
Per share, $
Per share, $ Revenue 37.18 44.52 53.27 50.81 48.00 76.76 89.25 100.38 93.97 87.14
Earnings 6.21 6.11 8.99 6.88 16.85 16.99 17.48 18.01 (13.93) (10.64)
Cash flow 6.16 5.82 11.60 11.73 11.40 15.80 16.78 17.45 8.84 10.46
Capex (1.70) (1.94) (2.51) (2.99) (3.09) (4.20) (5.01) (5.22) (3.98) (3.13)
Free cash flow 4.46 3.89 9.09 8.75 8.31 11.60 11.77 12.23 4.86 7.33
Book value 20.84 23.92 25.16 23.38 33.06 40.79 56.33 69.38 50.91 40.83
Shares, m 145 138 134 124 118 111 108 109 109 110
Valuation, ×
Valuation, × P/E 12.82 17.47 10.06 18.08 7.63 9.87 5.85 8.60 0.00 0.00
P/S 2.14 2.40 1.69 2.42 2.71 2.19 1.15 1.54 0.74 0.49
P/B 3.81 4.46 3.58 5.26 3.93 4.12 1.82 2.23 1.36 1.04
EV/Sales 2.57 2.89 2.12 2.96 3.10 2.59 2.51 2.63 1.87 1.67
EV/FCF 21.43 33.13 12.40 17.21 17.92 17.15 19.01 21.58 36.12 19.88
Cash, $m
Cash, $m Operating cash flow 893 803 1,558 1,454 1,343 1,757 1,819 1,899 966 1,146
Capex (246) (267) (337) (370) (364) (467) (543) (568) (435) (343)
Free cash flow 647 536 1,221 1,084 979 1,290 1,276 1,331 531 803
Balance, $m
Balance, $m Working capital 1,395 1,233 1,095 1,011 1,790 1,302 2,543 2,146 1,236 2,010
Total debt 3,008 3,641 3,531 3,905 3,723 3,967 14,679 13,684 12,579 12,598
Net debt 2,340 3,033 3,061 3,402 2,235 3,431 13,171 11,879 11,617 11,335
Shareholders’ equity 3,021 3,299 3,379 2,898 3,895 4,537 6,105 7,552 5,563 4,472
Returns, %
Returns, % ROA 10.62 9.42 12.81 9.07 19.48 16.52 9.90 7.35 (6.24) (5.23)
ROIC 10.89 8.46 12.95 8.27 6.77 15.26 4.47 5.36 (2.62) (3.11)
ROE 30.77 26.68 36.15 27.15 58.44 44.83 35.59 28.45 (23.52) (23.22)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Celanese Corporation vs peers in Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
DOW Dow Inc. $20.7B — (loss-making) 13.4× +19.68% (above 0%: growing) n/m +169.67% (above 0%: growing) 17.92% 7.29% Compare
CE Celanese Corporation $4.9B — (loss-making) 9.6× +8.69% (above 0%: growing) −37.36% (below 0%: shrinking) −53.63% (below 0%: shrinking) 22.46% 10.03%
OLN Olin Corporation $1.8B — (loss-making) — (loss-making) −0.93% (below 0%: shrinking) n/m −111.64% (below 0%: shrinking) 9.77% 2.67% Compare
HUN Huntsman Corporation $1.5B — (loss-making) — (loss-making) +14.06% (above 0%: growing) n/m −266.67% (below 0%: shrinking) 14.73% 2.22% Compare
REX REX American Resources Corporation $1.5B 11.5× 13.7× +17.87% (above 0%: growing) +393.02% (above 0%: growing) +392.23% (above 0%: growing) 28.52% 20.16% Compare
GPRE Green Plains, Inc. $1.1B 8.0× 8.2× −19.28% (below 0%: shrinking) n/m +57.21% (above 0%: growing) 25.33% 15.21% Compare
WLKP Westlake Chemical Partners LP $754.6M 13.0× 12.3× −0.01% (below 0%: shrinking) −2.44% (below 0%: shrinking) +866.65% (above 0%: growing) 31.91% 29.39% Compare
LXU Lsb Industries Inc. $729.3M 19.6× 12.8× +11.10% (above 0%: growing) n/m +9,653.02% (above 0%: growing) 6.82% (1.63%) Compare
TROX Tronox Holdings PLC $603.7M — (loss-making) — (loss-making) +18.74% (above 0%: growing) n/m +241.51% (above 0%: growing) 6.34% (2.42%) Compare
Median of peers $1.3B 12.2× 12.8× +12.58% — +205.59% 16.33% 4.98%

All 17 Chemicals stocks →

Celanese Corporation (CE) key facts

  • Concern: Celanese Corporation’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, down 7.05% from fiscal 2024.
  • Celanese Corporation (CE) is a Chemicals company in the Basic Materials sector, listed on the New York Stock Exchange.
  • As of October 9, 2026, CE traded at $45.02, a market capitalization of $4.9 billion.
  • Celanese Corporation pays an annual dividend of $0.12 per share, a yield of 0.27%.
  • Return on equity was −23.2% and debt-to-equity 2.62.
  • Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 1.23 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Celanese Corporation (CE) Latest News

No news at this impact. Lower the threshold for more.

stockrow.com/CE · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com